AstraZeneca PLC (NASDAQ:AZN)
| 65.09 BATS BZX Real-Time Price As of 9:46am ET |  +0.31 / +0.48%Today’s Change | 61.73 Today|||52-Week Range 76.56 | -4.00% Year-to-Date |
Institutional investors control 16.21% of the outstanding shares in AZN. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $8.5 million shares.
| Mutual fund holders | 9.09% |
| Other institutional | 7.12% |
| Individual stakeholders | -- |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 9/30/2023 | SANDERS CAPITAL LLC Bought 10.6 Million shares of AstraZeneca PLC |
| 9/30/2023 | VOYA INVESTMENT MANAGEMENT CO. L... Bought 2.7 Million shares of AstraZeneca PLC |
| 9/30/2023 | MANAGED ACCOUNT ADVISORS LLC Bought 2.0 Million shares of AstraZeneca PLC |
Top 10 Owners of AstraZeneca PLC
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Wellington Management Co. LLP | 1.60% | 49,492,814 | 3,129,430,629 | +358,399 | +0.73% |
| T. Rowe Price Associates, Inc. (I... | 1.46% | 45,259,535 | 2,861,760,398 | +633,875 | +1.42% |
| PRIMECAP Management Co. | 1.42% | 43,889,365 | 2,775,124,549 | -187,935 | -0.43% |
| Capital Research & Management Co.... | 1.12% | 34,618,579 | 2,188,932,750 | -3,721,186 | -9.71% |
| Jennison Associates LLC | 0.74% | 22,946,504 | 1,450,907,448 | +1,139,295 | +5.22% |
| GQG Partners LLC | 0.45% | 14,045,872 | 888,120,487 | -7,152,626 | -33.74% |
| Fidelity Management & Research Co... | 0.43% | 13,163,118 | 832,303,951 | -2,190,544 | -14.27% |
| Sanders Capital LLC | 0.34% | 10,561,101 | 667,778,416 | +10,561,101 | -- |
| CIBC Private Wealth Advisors, Inc... | 0.31% | 9,535,736 | 602,944,587 | -438,164 | -4.39% |
| Capital Research & Management Co.... | 0.30% | 9,335,762 | 590,300,231 | +189,758 | +2.07% |
Top 10 Mutual Funds Holding AstraZeneca PLC
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard PRIMECAP Fund | 0.83% | 25,805,588 | 1,631,687,329 | +145,000 | +0.57% |
| Washington Mutual Investors Fund | 0.73% | 22,459,265 | 1,420,099,326 | -4,220,545 | -15.82% |
| Vanguard Wellington Fund | 0.54% | 16,820,390 | 1,063,553,260 | -250,690 | -1.47% |
| American Mutual Fund | 0.37% | 11,350,526 | 717,693,759 | +798,097 | +7.56% |
| Invesco QQQ Trust | 0.32% | 10,047,701 | 635,316,134 | -1,808 | -0.02% |
| T Rowe Price Health Sciences Fund | 0.20% | 6,321,471 | 399,706,611 | -695,647 | -9.91% |
| Vanguard PRIMECAP Core Fund | 0.18% | 5,674,180 | 358,778,401 | -20,100 | -0.35% |
| Vanguard Equity Income Fund | 0.18% | 5,492,336 | 347,280,405 | -457,549 | -7.69% |
| Harbor Capital Appreciation Fund | 0.16% | 4,921,727 | 311,200,798 | +1,322,687 | +36.75% |
| Putnam Large Cap Value Fund | 0.15% | 4,607,933 | 291,359,604 | 0 | 0.00% |